Free Trial

Amplify Weight Loss Drug & Treatment ETF (THNR) Institutional Ownership

$25.33
+0.03 (+0.12%)
(As of 11/1/2024 ET)

Institutional Ownership Changes (13F Filings) for Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR)

Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$173.83K
Number of
Institutional Sellers
(last 12 months)
0
Get THNR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Amplify Weight Loss Drug & Treatment ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Amplify Weight Loss Drug & Treatment ETF Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/26/2024Harbour Investments Inc.6,668$174K0.0%N/A0.000%
(Data available from 1/1/2016 forward)

THNR Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of THNR shares?

During the previous two years, the following institutional investors and hedge funds held shares of Amplify Weight Loss Drug & Treatment ETF shares: Harbour Investments Inc. ($174K).Learn more on THNR's institutional investors.

Which institutional investors have been buying Amplify Weight Loss Drug & Treatment ETF stock?

The following institutional investors have purchased Amplify Weight Loss Drug & Treatment ETF stock in the last 24 months: Harbour Investments Inc. ($6.67K).

How much institutional buying is happening at Amplify Weight Loss Drug & Treatment ETF?

Institutional investors have bought a total of 6,668 shares in the last 24 months. This purchase volume represents approximately $173.83K in transactions.



This page (NYSEARCA:THNR) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners